Unichem Laboratories informs about press release

16 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed a press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

852.75 -3.35 (-0.39%)
25-Nov-2024 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.00
Dr. Reddys Lab 1216.45
Cipla 1492.95
Lupin 2102.40
Zydus Lifesciences 955.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.